Boai NKY Pharmaceuticals Ltd Capital Reinvestment Ratio
Boai NKY Pharmaceuticals Ltd capital reinvestment ratio. Boai NKY Pharmaceuticals Ltd (300109) has a Capital Reinvestment Ratio of 0.30x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥139.46 Million) in capital expenditures (CN¥41.41 Million). Check Boai NKY Pharmaceuticals Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Boai NKY Pharmaceuticals Ltd (2007–2025)
Capital reinvestment ratio of Boai NKY Pharmaceuticals Ltd from 2007 to 2025. This chart tracks Boai NKY Pharmaceuticals Ltd's Capital Reinvestment Ratio across 18 annual periods. Also explore Boai NKY Pharmaceuticals Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Boai NKY Pharmaceuticals Ltd Capital Reinvestment Ratio by Year (2007–2025)
Boai NKY Pharmaceuticals Ltd capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Boai NKY Pharmaceuticals Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.65x | CN¥338.11 Million | CN¥220.42 Million | ▼ -39.2% |
| 2024 | 1.07x | CN¥256.03 Million | CN¥274.68 Million | ▲ +38.6% |
| 2023 | 0.77x | CN¥488.25 Million | CN¥377.88 Million | ▼ -26.7% |
| 2022 | 1.06x | CN¥251.77 Million | CN¥266.00 Million | ▼ -79.9% |
| 2021 | 5.26x | CN¥43.44 Million | CN¥228.32 Million | ▲ +1313.4% |
| 2020 | 0.37x | CN¥266.87 Million | CN¥99.24 Million | ▼ -79.2% |
| 2019 | 1.79x | CN¥79.64 Million | CN¥142.35 Million | ▼ -29.9% |
| 2018 | 2.55x | CN¥48.81 Million | CN¥124.37 Million | ▼ -6.8% |
| 2017 | 2.73x | CN¥47.28 Million | CN¥129.23 Million | ▲ +543.7% |
| 2016 | 0.42x | CN¥114.14 Million | CN¥48.47 Million | ▼ -32.7% |
| 2015 | 0.63x | CN¥64.12 Million | CN¥40.48 Million | ▼ -37.6% |
| 2014 | 1.01x | CN¥46.60 Million | CN¥47.11 Million | ▼ -34.0% |
| 2013 | 1.53x | CN¥23.17 Million | CN¥35.47 Million | ▼ -65.3% |
| 2012 | 4.41x | CN¥20.65 Million | CN¥90.96 Million | ▼ -83.4% |
| 2011 | 26.46x | CN¥3.94 Million | CN¥104.29 Million | ▲ +1144.2% |
| 2010 | 2.13x | CN¥10.05 Million | CN¥21.38 Million | ▲ +140.5% |
| 2009 | 0.88x | CN¥28.57 Million | CN¥25.27 Million | ▲ +77.3% |
| 2007 | 0.50x | CN¥9.56 Million | CN¥4.77 Million | — |